Colombia vs New Zealand: Share of one-year-olds vaccinated against Haemophilus influenzae type B
Colombia
89.0%
in 2024
New Zealand
89.0%
in 2024
Colombia rank
109th
New Zealand rank
109th
Share of one-year-olds vaccinated against Haemophilus influenzae type B over time
- Colombia
- New Zealand
How they compare
Colombia currently reports 89.0% against 89.0% in New Zealand, a difference of 0.0%.
The two have swapped places 6 times across 27 shared years of data; in 1998 it was New Zealand ahead.
Colombia ranks 109th and New Zealand ranks 109th of 192 countries.
New Zealand has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Colombia | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 63.0% | 84.5% | 21.5% | New Zealand |
| 2000s | 83.5% | 85.8% | 2.3% | New Zealand |
| 2010s | 90.4% | 92.1% | 1.7% | New Zealand |
| 2020s | 88.2% | 89.6% | 1.4% | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of one-year-olds vaccinated against haemophilus influenzae type b, Colombia or New Zealand?
- Colombia, at 89.0% against 89.0% in New Zealand as of 2024.
- What is the difference in share of one-year-olds vaccinated against haemophilus influenzae type b between Colombia and New Zealand?
- 0.0%, with Colombia ahead.
- How many years of comparable data are there for Colombia and New Zealand?
- 27 years are reported by both, from 1998 to 2024.
- How do Colombia and New Zealand rank globally for share of one-year-olds vaccinated against haemophilus influenzae type b?
- Colombia ranks 109th and New Zealand ranks 109th of 192 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Share of one-year-olds vaccinated against Haemophilus influenzae type B. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had three doses of Haemophilus influenzae type b vaccine in a given year.